Midlife women miss out: RANZCP treatment guidelines for schizophrenia should consider the lifestage needs of midlife women.

Abstract

Midlife women are given no specific mention in the recently published Grading of Recommendations, Assessment, Development and Evaluation guidelines for schizophrenia, likely due to the lack of randomised controlled trial-level research or even consensus guidelines dedicated to this overlooked group. We argue here that midlife women with schizophrenia have specific needs which require tailored individualised care.